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SUMMARY 
 
Background 
The increasing prevalence of extended-spectrum β-lactamase (ESBL)-
producing Enterobacteriacae in the healthcare setting and in the community 
despite established infection control guidelines indicates that these 
microorganisms may possess survival strategies that allow them to persist in 
the environment. 
Aims 
To determine the extent and variation in endemic ESBL-carrying species in 
different ward environments. 
To investigate the potential for cephalosporin resistance to be transferred from 
environmental isolates to human pathogens. 
Methods 
Conventional microbiological methods were used to sample 1436 
environmental surfaces for ESBL-producing bacteria. Transconjugation 
assays (broth mating experiments) were performed using environmental 
ESBL-producing isolates as donors and streptomycin-resistant Escherichia 
coli (NCTC 50237) as the recipient.  
Findings 
The prevalence of ESBL-producing bacteria on surfaces in a non-outbreak 
setting was low (45/1436; 3.1%). The sites most likely to be contaminated 
were the drains of handwash basins (28/105; 26.7%) and floors (14/160; 
8.8%). Fifty-nine ESBL-carrying organisms were isolated. Of these, Klebsiella 
spp (33.9%), Enterobacter spp (20.3%), Pantoea spp (15.3%) and Citrobacter 
spp (13.6%), were the most common isolates. ESBL determinants were 
successfully transferred from three representative environmental isolates 
(Pantoea calida, Klebsiella oxytoca, Raoultella ornithinolytica) to the human 
pathogen E. coli. 
Conclusion 
ESBL-producing Gram-negative isolates were recovered from the hospital 
environment in the absence of any ESBL infection on the wards.  
The drains of hand wash basins should be considered potential long-term 
reservoirs of multi-drug resistant bacteria and drug resistance genes. These 
genes can reside in various genera of hardy environmental organisms and be 
a potential source of ESBL for more common human pathogens.  
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Introduction  
 
With increasing use of broad spectrum antimicrobials and seriously ill patients 
surviving for longer periods, multidrug resistance (MDR) has significantly 
increased in the last decade and has emerged as a global concern.  
At the same time fewer new antibiotics are becoming available and the World 
Health Organization has developed a global action plan to tackle antibiotic 
resistance.1 In the United Kingdom (as in the rest of Europe), the rapid 
evolution and spread of MDR Gram-negative bacteria among hospitalised 
patients is of particular concern.2, 3  
The increased prevalence of Enterobacteriaceae resistant to extended 
spectrum cephalosporins has been caused by the circulation of different 
plasmids containing a diversity of extended spectrum β-lactamase (blaESBL) 
genes.4 The genes encoding for CTX-M type ESBL enzymes are normally 
found on the chromosome of Kluyvera species. Kluyvera spp are ubiquitous 
within the environment (water, soil, hospital sinks) but rarely cause infections 
in humans. However, they are able to transfer the genes encoding for CTX-M 
enzymes to other Gram-negative bacteria.5 Horizontal gene transfer requires 
DNA from one cell to be physically transferred to another. The DNA must then 
be incorporated into the recipient’s genome so that it can be stably inherited. 
Horizontal gene transfer by plasmid mediated conjugation is thought to play 
an important role in the adaptation of bacteria to various conditions in the 
clinical environment.6  
 
Gram-negative organisms can lose viability rapidly under dry conditions 7; as 
such the role of environmental reservoirs in the transmission of ESBL infection 
is often overlooked. However, most nosocomial pathogens can persist on 
inanimate surfaces for many weeks 8 and prolonged environmental survival of 
carbapenem-resistant Klebsiella pneumoniae and ESBL-producing 
Escherichia coli has been demonstrated. 9, 10 The surfaces most likely to be 
contaminated with MDR Gram-negative organisms are those associated with 
sinks, toilet and shower facilities.11 The presence of moisture facilitates 
bacterial survival and an increasing number of outbreaks have been linked to 
hospital sinks and taps. 12-14  
 
This study seeks to determine the extent and variation in ESBL-carrying 
Gram-negative species in different types of hospital ward environment and to 
demonstrate the potential pathogenic importance of environmental reservoirs 
of ESBL-producing bacteria in the transmission of Gram-negative infection in 
the healthcare setting. 
 
 
Methods 
 
Study Setting 
A microbiological survey of 13 different ward environments (located in seven 
different buildings) was carried out at a UK teaching hospital over a 4 month 
period. Patients were not screened routinely for carriage of ESBL. Rooms 
occupied by patients colonised/infected with ESBL-producing 
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Enterobacteriacae were not specifically targeted to sample. There was no 
outbreak during the study. 
Environmental Sampling 
 
Sampling focused on those areas considered most likely to harbour Gram-
negative organisms (e.g. sinks; showers) in patient rooms, toilets and 
bathrooms. Sampling was also performed in non-clinical areas including 
beverage bays, visitor toilets, staff toilets, changing rooms, sluice rooms, 
corridors and kitchens on different speciality wards.  
A total of 1436 surfaces (1006 clinical; 430 non-clinical) were assessed for 
contamination with ESBL-producing bacteria (Table I).  
Each environmental site was sampled using a non-selective blood agar 
contact plate (diameter 55 mm; Oxoid, Basingstoke, UK). An R2A agar 
contact plate (supplemented with 0.5% Tween and 0.07% lecithin; diameter 
55 mm; Southern Group Limited, Corby, UK) was used to sample an adjacent 
test area for less fastidious organisms.  Cotton swabs, pre-moistened with 
phosphate-buffered saline (Oxoid), were used to sample two irregular-shaped 
surfaces (drain and tap aerator). Swabs were directly plated onto Columbia 
agar with horse blood and R2A agar plates (diameter 90 mm; Oxoid).  
Blood and R2A agar plates were incubated aerobically at 37°C for 48 hours 
and room temperature for 5-7 days respectively.  
 
Microbiological Analysis 
 
Presumptive Gram-negative colonies were Gram-stained and tested for their 
ability to ferment lactose. Presumptive Enterobacteriacae isolates were 
screened for resistance to cefpodoxime (10µg). Resistant isolates (≤19 mm 
zone diameter)15 were tested for ESBL and AmpC production (MASTDISCS™ 
AmpC and ESBL ID set Mast Group Ltd, Bootle, UK). Organisms 
demonstrating AmpC activity alone were discarded.  
Presumptive P. aeruginosa isolates were screened for resistance to 
ceftazidime (30 µg). Resistant isolates were also assessed for ESBL 
production (MASTDISCS™ ESBL ceftazidime paired ID).  
 
Identification to species level was performed using the oxidase test and either 
API 20E or API 20NE biochemical test strips (BioMérieux, Basingstoke, UK). 
Isolates that did not provide an acceptable profile were identified via Matrix 
Assisted Laser Desorption/Ionisation – Time of Flight (MALDI-TOF) mass 
spectrometry. All ESBL-producing isolates were sub-cultured and stored at -
20°C on porous ceramic beads. 
 
Conjugation Assay 
 
Conjugation assays were performed using a broth mating method16 to 
investigate the transferability of genetic material from environmental isolates 
to a representative human pathogen. Streptomycin-sensitive ESBL-producing 
isolates recovered from the ward environment were used as donors and 
streptomycin resistant E. coli NCTC 50237 (HB101) was used as the 
recipient. The donor and recipient strains were mixed together at the ratio of 
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1:5 (1mL:5mL of cultures of same concentration) respectively in nutrient broth 
and the suspension incubated overnight at 37°C. Transconjugants were 
selected on nutrient agar supplemented with streptomycin (0.1 g/L) to inhibit 
the growth of the donor and ceftazidime (4 mg/L) (Sigma-Aldrich Ltd., 
Gillingham, UK) to inhibit the growth of the recipient strain. Recovered 
colonies were confirmed as E. coli using API 20E. Transconjugants were 
passaged 15 times on nutrient agar without antibiotics to confirm stability. 
Each mating experiment was repeated in triplicate. 
The recipient, donor and transconjugant isolates were subjected to antibiotic 
sensitivity testing. The susceptibility to meropenem (10 µg), gentamicin (10 
µg), amikacin (30 µg), ciprofloxacin (1 µg), piperacillin/tazobactam (75/10 µg), 
cefotaxime (30µg), ceftazidime (30 µg) and streptomycin (10 µg) (Oxoid) was 
determined according to the criteria established by the British Society for 
Antimicrobial Chemotherapy (BSAC).15 
 
 
Results 
 
Microbiological Survey 
 
ESBL-producing Gram negative isolates were recovered from 45 (3.1%) of the 
1436 surfaces sampled (Table I).  
ESBL-producing bacteria were not recovered from any of the surfaces 
sampled in any out-patient clinic (n=125). The wards with the highest number 
of contaminated sites were a private ward (10.3%); a haematology ward 
(6.5%) and the intensive care unit (ICU; 6.4%) (Table II).  
 
Three rooms were occupied by a patient with an ESBL infection; 13.3% of 
sites were positive for ESBL-producing bacteria (6/45). In contrast, 2.7% 
(37/1391) of sites were positive in areas with no known infected/colonised 
patient. 
 
The sites most likely to harbour ESBL-producing bacteria were the drain hole 
of hand wash basins (28/105) and the toilet floor (8/44) (Table I). ESBL-
carrying bacteria were not recovered from 16 of 22 sample points on any 
sampling occasion. These included high-contact sites in patient rooms (e.g. 
computer keyboard, bed rail, nurse call button), door handles, showers and 
taps. 
 
More than one species of ESBL-producer was recovered from the same 
sample point on eleven occasions (Table III). Of the 59 ESBL-positive isolates 
Klebsiella sp. was the most common genus specifically K. pneumoniae (n=11) 
and K. oxytoca (n=9).  
Enterobacter sp. was the second most numerous genus (12 isolates; 
20.34%). 
 
Fifty-two of the 59 ESBL-producing isolates were recovered in patient room 
(single isolation rooms, bays and patient toilets, bathrooms). Seven isolates 
were detected within non-clinical areas i.e. a staff toilet, three beverage bays, 
a kitchen, a reception and a corridor. 
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Pantoea calida, a recently described non-human pathogen17 was identified via 
MALDI-TOF and was recovered from the drain of a hand wash basin and from 
the floors of patient rooms and toilets, beverage bays and staff toilet. P. calida 
was recovered from six different wards located in two different buildings of the 
hospital.  
 
Conjugation Assay 
 
Three environmental isolates (Pantoea calida, Klebsiella oxytoca, Raoultella 
ornithinolytica) were sensitive to streptomycin and were selected as donors. 
Cephalosporin resistance - co-transferred with gentamicin resistance - was 
successfully transferred from each donor isolate to E. coli.  
The antibiotic susceptibility profile of the 15th generation transconjugants 
remained the same confirming stability of the inheritance (Table IV). 
 
 
Discussion 
 
In a non-outbreak setting, the number of surfaces contaminated with ESBL-
producing organisms was low (3.1% of all surfaces sampled). The 
environment of patients known to be colonised/infected with ESBL-producing 
Enterobacteriaceae was most likely to be contaminated.  
If we had specifically targeted rooms/bays occupied by infected patients, more 
environmental ESBL-producing organisms may have been detected. 
Nonetheless, ESBL-producing bacteria were recovered from the ward 
environment in the absence of infected patients; most commonly from 
surfaces within a private ward, the ICU and a haematology ward (Table II) 
Contaminated surfaces contribute to the transmission of hospital pathogens18 
and whilst some studies suggest that environmental contamination may not 
play a role in the transmission of ESBL-producing pathogens19 others have 
concluded that admission to a room previously occupied by an 
infected/colonised patient is a risk factor for acquisition.20  
The majority of patients admitted to the private ward originated from the 
Middle East where very high rates of ESBL production among 
Enterobacteriaceae have been reported 21 and which may have contributed to 
the comparatively high surface contamination rate.  ESBL- K. pneumoniae 
was recovered from the toilet floor, toilet seat and a bin lid in a private room 
three days before the occupying patient (not known to be colonised at the time 
of sampling) presented with a urinary tract infection. However, ESBL-K. 
pneumoniae was recovered from the clinical sample the isolate was not 
available for molecular typing and, as such, the similarity between the 
environmental and clinical isolates could not be determined.  
 
More than one species of ESBL-producing bacteria was recovered from the 
same environmental site on several occasions, reflecting perhaps the diversity 
of organisms carried by patients, particularly those in intensive care. 
Consumption of antibiotics is also higher in ICUs and exposure of bacteria to 
sub-therapeutic concentrations can help drive the selection and spread of 
antibiotic-resistant strains.22 It was interesting to note the different isolation 
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rate of ESBLs on the two haematology wards environment. Haematology I. 
(Table II) where the isolation rate was higher (6.5%) cared for patients with 
bone marrow transplant for longer admission in single isolation rooms only. 
Patients on Haematology II were undergoing chemotherapy for shorter 
admission, stayed in both open bay and single rooms.  
 
ESBL- P. calida was recovered from the floor of six different wards located in 
two different buildings. Both buildings are under the same estate 
management.  
Re-analysis of our environmental strain collection using the MALDI-TOF 
confirmed that ESBL- P. calida had been isolated during previous studies, not 
only from floors but also from sinks, towel dispensers, door handles and 
cleaning cloths (unpublished data), suggesting the organism is well-
established within the hospital microbiome. Persistence within the hospital 
environment may be due to desiccation-resistance and/or an increased 
tolerance to disinfectants and, thus, the ability to survive the cleaning process; 
both can be facilitated by the formation of biofilm.23 
 
Drain biofilms harbour large populations of bacteria,24 including antibiotic-
resistant strains and hospital sink drains have been implicated in a number of 
outbreaks of multidrug-resistant bacteria.25-29 Our study confirmed that the 
drain of the handwash basin in patient room is a potential reservoir for ESBL-
producing Enterobacteriacae and P. aeruginosa. It accounted for 62% of 
ESBL-positive sites.  
The drains most likely to be contaminated were located in a haematology 
ward (5/10), the neonatal unit (NNU; 4/8) and the ICU (11/24). However, 
species diversity differed with ward. Drains located in the NNU were 
contaminated with an E. cloacae strain, whereas multiple species were 
recovered from the haematology ward and ICU.  For example,  ESBL-K. 
pneumoniae, Citrobacter freundii and Enterobacter asburiae were recovered 
from a handwash basin located in haematology. Similarly, a single ICU drain 
harboured ESBL-K. pneumoniae, K. oxytoca and P. aeruginosa.  
Eradication of ESBL-producing Enterobacteriacae from sinks is difficult 14, 29 
and, consequently, contaminated drains can act as long-term reservoirs of 
multi-drug resistant bacteria and facilitate the contamination of the ward 
environment. Studies have demonstrated that drain contents can be dispersed 
on to surfaces outside of the drain, via splash-back and/or aerosolisation.14, 29 
 
 
Many of the environmental bacteria (e.g. Pantoea sp, Raoultella sp.) 
recovered in our survey rarely cause humans harm.30, 31 However, they were 
able to transfer cephalosporin resistance to bacteria that do infect patients. 
Horizontal gene transfer will happen most frequently in areas of high bacterial 
density.32 Hospital sink drains should be considered a source of antibiotic 
resistance genes not just a source of antibiotic resistant bacteria. 
 
In this study, surface contamination was detected using culture methods only. 
The number and type of resistant isolates recovered from the environment 
could represent a small proportion of the resistant flora in the hospital 
ecosystem.  
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Our study demonstrates that antimicrobial resistance genes could be easily 
imported from the hospital environmental microbiota and indirectly be 
disseminated via conjugation with pathogenic species and highlights the 
potential of hospital waste outlets to act as a reservoir for healthcare-acquired 
infections caused by ESBL-producing Gram-negative bacteria. 
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